Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:57 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532300 | NSE: WOCKPHARMA

Wockhardt Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹531.51Overvalued by 58.08%vs CMP ₹1,268.00

P/E (190.0) × ROE (1.2%) × BV (₹281.00) × DY (2.00%)

₹424.65Overvalued by 66.51%vs CMP ₹1,268.00
MoS: -198.6% (Negative)Confidence: 60/100 (Moderate)Models: All 6: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹960.6732%Over (-24.2%)
Graham NumberEarnings₹92.3919%Over (-92.7%)
Net Asset ValueAssets₹281.1415%Over (-77.8%)
EV/EBITDAEnterprise₹299.4213%Over (-76.4%)
Earnings YieldEarnings₹13.5010%Over (-98.9%)
Revenue MultipleRevenue₹185.4211%Over (-85.4%)
Consensus (6 models)₹424.65100%Overvalued
Key Drivers: EPS CAGR 80.7% lifts DCF — verify sustainability. | P/E of 190 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 80.7%

*Investments are subject to market risks

Investment Snapshot

41
Wockhardt Ltd scores 41/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health30/100 · Weak
ROCE 3.8% WeakROE 1.2% WeakD/E 0.46 ModerateInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent
Smart Money60/100 · Moderate
FII holding up 0.18% (6mo) Slight increasePromoter holding at 49.1% Stable
Earnings Quality50/100 · Moderate
OPM stable around 8% Steady
Quarterly Momentum60/100 · Moderate
Revenue (4Q): +6% YoY Growing
Industry Rank10/100 · Weak
P/E 190.0 vs industry 53.8 Premium to peersROCE 3.8% vs industry 16.4% Below peersROE 1.2% vs industry 15.2% Below peers3Y sales CAGR: -2% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Wockhardt Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
70/100
High
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 190.0 vs Ind 53.8 | ROCE 3.8% | ROE 1.2% | CFO/NP N/A
Balance Sheet Stress
40/100
Manageable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.46x | IntCov 0.0x | Current 0.77x | Borrow/Reserve 0.55x
Cash Flow Reliability
71/100
Mixed
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹-57 Cr | CFO/NP N/A
Ownership Accumulation
-75
Distribution
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII -0.10 pp | DII -0.45 pp | Prom 0.00 pp
Business Momentum
-29
Early weakness
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales +13.6% | Q NP -25.6% | Q OPM -3.0 pp
Derived FieldValueHow it is derived
Valuation Gap %-66.5%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.55xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII Change-0.10 ppLatest FII% minus previous FII%
DII Change-0.45 ppLatest DII% minus previous DII%
Promoter Change0.00 ppLatest promoter% minus previous promoter%
Shareholder Count Change+4,328Latest shareholder count minus previous count
Quarterly Sales Change+13.6%Latest quarter sales vs previous quarter sales
Quarterly Profit Change-25.6%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change-3.0 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:57 am

Market Cap 20,598 Cr.
Current Price 1,268
Intrinsic Value₹424.65
High / Low 1,870/1,087
Stock P/E190
Book Value 281
Dividend Yield0.00 %
ROCE3.75 %
ROE1.22 %
Face Value 5.00
PEG Ratio2.35

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Wockhardt Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Wockhardt Ltd 20,598 Cr. 1,268 1,870/1,087190 2810.00 %3.75 %1.22 % 5.00
Astrazeneca Pharma India Ltd 19,630 Cr. 7,852 10,691/6,50294.4 3200.41 %33.4 %23.6 % 2.00
Acutaas Chemicals Ltd 19,093 Cr. 2,332 2,688/93066.5 1730.06 %19.9 %16.0 % 5.00
Pfizer Ltd 22,201 Cr. 4,853 5,993/3,70129.2 8410.72 %21.6 %16.4 % 10.0
ERIS Lifesciences Ltd 18,152 Cr. 1,310 1,910/1,09740.9 2270.56 %12.2 %12.9 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Wockhardt Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 699678644753701700739809721743738782888
Expenses 654675628681664759648699593679666604711
Operating Profit 453167237-59911101286472178177
OPM % 6%0%2%10%5%-8%12%14%18%9%10%23%20%
Other Income -1-64024810309815-772115
Interest 83767976777373736048485560
Depreciation 66565555555854555553565365
Profit before tax -105-193-118-35-87-180-6-921-22-1099167
Tax % -3%23%15%109%-1%-2%167%78%5%105%-1%10%9%
Net Profit -102-237-136-73-86-177-16-1620-45-1088261
EPS in Rs -6.66-14.44-9.30-5.34-5.76-11.02-0.91-1.430.86-1.54-5.544.803.63

Last Updated: March 3, 2026, 1:46 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 11:46 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 4,8304,4824,4534,0153,9373,5662,8442,7083,2302,6512,7983,0123,151
Expenses 3,8053,7723,9594,0023,9353,6042,7252,7712,9322,5502,7072,6192,660
Operating Profit 1,026709494132-38119-6329810191393491
OPM % 21%16%11%0%0%-1%4%-2%9%4%3%13%16%
Other Income 886766114-238116133975-163-1721762-26
Interest 8355129225255265276249299302305254211
Depreciation 140145142149150164224246247251223217227
Profit before tax 891575289-247-641-351-247417-411-624-420-1627
Tax % 5%28%13%-9%4%-38%-82%-65%-32%-0%12%256%
Net Profit 843413252-226-667-217-43689-279-621-472-57-10
EPS in Rs 58.9128.3017.45-13.62-42.30-13.52-4.8147.64-16.94-38.80-30.18-2.891.35
Dividend Payout % 13%54%0%-56%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-51.01%-38.98%-189.68%-195.13%67.47%80.18%1702.33%-140.49%-122.58%23.99%87.92%
Change in YoY Net Profit Growth (%)0.00%12.03%-150.70%-5.45%262.60%12.72%1622.14%-1842.82%17.91%146.57%63.93%

Wockhardt Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:-4%
5 Years:1%
3 Years:-2%
TTM:4%
Compounded Profit Growth
10 Years:%
5 Years:6%
3 Years:15%
TTM:85%
Stock Price CAGR
10 Years:3%
5 Years:40%
3 Years:79%
1 Year:36%
Return on Equity
10 Years:-2%
5 Years:0%
3 Years:-7%
Last Year:-1%

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: December 10, 2025, 3:40 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 55555555555555557272778181
Reserves 3,2283,3623,7203,2812,7972,6192,6163,3213,7773,2823,2824,2724,486
Borrowings 2,2052,3092,6774,1603,7483,3753,5822,6732,1982,1842,3562,0212,456
Other Liabilities 1,1341,2131,6221,4861,5281,7641,8941,6952,1682,1131,8991,7261,510
Total Liabilities 6,6226,9398,0748,9828,1287,8138,1487,7448,2157,6517,6148,1008,533
Fixed Assets 2,2952,1232,8092,7732,8883,0583,5023,3433,4623,0422,8812,7364,396
CWIP 7081,0071,0361,2441,4331,4451,5851,3791,3421,5391,7222,033583
Investments 5773410563214000000422696
Other Assets 3,0433,4684,2284,4033,5933,3093,0603,0223,4113,0703,0112,9092,858
Total Assets 6,6226,9398,0748,9828,1287,8138,1487,7448,2157,6517,6148,1008,533

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 1,476355-42-26968183649-287413153219-22
Cash from Investing Activity + -823-222-105-68463593-1471,471-204-118-138-780
Cash from Financing Activity + -601-761931,254-769-776-680-1,171-71-315334409
Net Cash Flow 525746301-66-500-17813138-280415-393
Free Cash Flow 1,018-76-105-678-238127486-4522022369-377
CFO/OP 157%73%-8%-1,887%4,697%-583%560%270%171%162%274%-13%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-1.00707.00492.009.00-1.00-41.00116.00-65.00296.0099.0089.00391.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 36609194891301591241041108180
Inventory Days 201250249243174183209256222216201234
Days Payable 113136144117122187272223265285240191
Cash Conversion Cycle 12417519622014112697157604141123
Working Capital Days -7145236-56-51-171-133-116-186-163-23
ROCE %18%10%7%-1%-1%-1%0%12%1%-0%-1%4%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 59.31%58.40%55.14%54.93%51.60%51.99%51.99%49.09%49.09%49.09%49.09%49.09%
FIIs 2.78%2.60%3.03%4.18%5.49%5.94%6.70%6.54%6.82%7.29%7.10%7.00%
DIIs 0.22%0.18%0.21%0.30%4.82%4.45%5.08%9.82%10.58%11.00%11.00%10.55%
Government 0.00%0.00%0.00%0.00%0.01%0.01%0.02%0.02%0.02%0.02%0.02%0.02%
Public 37.70%38.83%41.62%40.59%38.06%37.62%36.21%34.54%33.50%32.60%32.79%33.36%
No. of Shareholders 1,82,4931,78,9151,72,9891,61,8131,46,1381,40,3911,38,1421,42,7101,41,7991,46,9181,37,9461,42,274

Shareholding Pattern Chart

No. of Shareholders

Wockhardt Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Tata Small Cap Fund 2,022,338 2.57 275.422,020,0532026-02-23 00:45:130.11%
HSBC Small Cap Fund 1,325,150 1.17 180.47N/AN/AN/A
Mirae Asset ELSS Tax Saver Fund 1,323,021 0.69 180.18756,5852026-02-22 14:24:0074.87%
Tata Large & Mid Cap Fund 978,826 1.64 133.31N/AN/AN/A
ICICI Prudential ELSS Tax Saver Fund 812,752 0.77 110.69837,7522026-01-25 00:23:17-2.98%
Bandhan Small Cap Fund 601,354 0.4 81.9581,3542026-01-26 08:21:043.44%
Invesco India Smallcap Fund 575,064 0.81 78.32N/AN/AN/A
HSBC Flexi Cap Fund 482,261 1.24 65.68446,1612026-02-22 09:37:428.09%
Invesco India Contra Fund 466,063 0.32 63.47N/AN/AN/A
Bank of India Small Cap Fund 440,000 3.15 59.92N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) -3.02-32.05-38.79-20.2461.95
Diluted EPS (Rs.) -3.02-32.05-38.79-20.2461.68
Cash EPS (Rs.) 9.88-16.17-25.69-2.2284.37
Book Value[Excl.RevalReserv]/Share (Rs.) 268.70237.79254.31291.81339.43
Book Value[Incl.RevalReserv]/Share (Rs.) 268.70237.79254.31291.81339.43
Revenue From Operations / Share (Rs.) 185.93181.69184.10224.31244.48
PBDIT / Share (Rs.) 28.097.9215.4922.086.25
PBIT / Share (Rs.) 14.69-6.56-1.944.93-15.96
PBT / Share (Rs.) -0.98-27.27-43.33-28.5481.42
Net Profit / Share (Rs.) -3.52-30.65-43.13-19.3862.16
NP After MI And SOA / Share (Rs.) -2.90-30.06-38.82-16.9461.93
PBDIT Margin (%) 15.104.368.419.842.55
PBIT Margin (%) 7.90-3.60-1.052.19-6.52
PBT Margin (%) -0.53-15.01-23.53-12.7233.30
Net Profit Margin (%) -1.89-16.86-23.42-8.6325.42
NP After MI And SOA Margin (%) -1.56-16.54-21.08-7.5525.33
Return on Networth / Equity (%) -1.07-13.78-16.66-6.3320.31
Return on Capital Employeed (%) 3.90-2.07-0.651.40-3.79
Return On Assets (%) -0.57-6.05-7.27-2.968.82
Long Term Debt / Equity (X) 0.270.260.060.090.14
Total Debt / Equity (X) 0.420.620.560.480.46
Asset Turnover Ratio (%) 0.380.360.330.200.15
Current Ratio (X) 1.260.780.640.800.77
Quick Ratio (X) 0.900.550.450.560.52
Inventory Turnover Ratio (X) 4.410.950.720.470.48
Interest Coverage Ratio (X) 1.790.400.731.060.27
Interest Coverage Ratio (Post Tax) (X) 0.77-0.50-0.080.670.38
Enterprise Value (Cr.) 25036.7510872.674287.885607.726250.83
EV / Net Operating Revenue (X) 8.313.891.621.742.31
EV / EBITDA (X) 55.0389.1219.2317.6390.28
MarketCap / Net Operating Revenue (X) 7.663.210.831.181.69
Price / BV (X) 5.302.680.660.981.36
Price / Net Operating Revenue (X) 7.663.210.831.181.69
EarningsYield 0.00-0.05-0.25-0.060.14

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1402.00 Cr. and Equity Capital is Rs. 81.00 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsD-4, MIDC, Aurangabad Maharashtra 431006Contact not found
Management
NamePosition Held
Dr. Habil KhorakiwalaFounder Chairman
Dr. Murtaza KhorakiwalaManaging Director
Dr. Huzaifa KhorakiwalaExecutive Director
Ms. Zahabiya KhorakiwalaNon Executive Director
Mrs. Tasneem MehtaIndependent Director
Mr. Vinesh Kumar JairathIndependent Director
Mr. Akhilesh GuptaIndependent Director
Ms. Amelia FernandesIndependent Director
Mr. Ahmad JavedIndependent Director

FAQ

What is the intrinsic value of Wockhardt Ltd and is it undervalued?

As of 06 April 2026, Wockhardt Ltd's intrinsic value is ₹424.65, which is 66.51% lower than the current market price of ₹1,268.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (1.22 %), book value (₹281), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Wockhardt Ltd?

Wockhardt Ltd is trading at ₹1,268.00 as of 06 April 2026, with a FY2026-2027 high of ₹1,870 and low of ₹1,087. The stock is currently near its 52-week low. Market cap stands at ₹20,598 Cr..

How does Wockhardt Ltd's P/E ratio compare to its industry?

Wockhardt Ltd has a P/E ratio of 190, which is above the industry average of 53.84. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Wockhardt Ltd financially healthy?

Key indicators for Wockhardt Ltd: ROCE of 3.75 % is on the lower side compared to the industry average of 16.35%; ROE of 1.22 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Wockhardt Ltd profitable and how is the profit trend?

Wockhardt Ltd reported a net profit of ₹-57 Cr in Mar 2025 on revenue of ₹3,012 Cr. Compared to ₹-279 Cr in Mar 2022, the net profit shows a mixed trend.

Does Wockhardt Ltd pay dividends?

Wockhardt Ltd has a dividend yield of 0.00 % at the current price of ₹1,268.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Wockhardt Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports